Literature DB >> 6191763

Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay.

J M Stuart, E H Huffstutter, A S Townes, A H Kang.   

Abstract

Antibodies to human native and denatured types I, II, III, IV, and V collagens were measured using 125I-radioimmunoassay. Mean levels of binding by sera from 30 rheumatoid arthritis patients were significantly higher than those from 20 normal subjects against all of the collagens tested. The relative antibody concentration was higher in synovial fluid than in simultaneously obtained serum. Many patients with gout or various other rheumatic diseases also had detectable anticollagen antibodies. With a few notable exceptions, the majority of the reactivity detected in all patient groups was directed against covalent structural determinants present on all of the denatured collagens, suggesting a secondary reaction to tissue injury.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191763     DOI: 10.1002/art.1780260703

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  35 in total

1.  Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant.

Authors:  Henry Yim Wu; Ruth Maron; Ann-Marcia Tukpah; Howard L Weiner
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

2.  The immune response of guinea-pigs to type II collagen: poor cross-reactivity with homologous type II collagen accounts for resistance to collagen-induced arthritis.

Authors:  A D Hernandez; M A Cremer; A S Townes; J M Stuart; A H Kang
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

3.  Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeys.

Authors:  S Turner; N P Bakker; B A t Hart; P J Holt; K Morgan
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

Review 4.  What do anti-collagen antibodies mean?

Authors:  K Morgan
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

Review 5.  Analysis of T cell clones in rheumatoid arthritis.

Authors:  M Feldmann; M Londei; Z Leech; F Brennan; C Savill; R N Maini
Journal:  Springer Semin Immunopathol       Date:  1988

6.  Pattern of humoral reactivity to type II collagen in rheumatoid arthritis.

Authors:  M C Boissier; G Chiocchia; B Texier; C Fournier
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

7.  The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice.

Authors:  S Yoshino; M Ohsawa
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

8.  Pepsinogen--an immunoglobulin binding artefact in 'collagen' preparations.

Authors:  A P Kirk; B P O'Hara; R A Mageed; M S McMahon; D McCarthy; S Menashi; J R Archer; H L Currey
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

9.  Activity of rheumatoid arthritis and levels of collagen antibodies: a prospective study.

Authors:  A Stockman; M J Rowley; P Emery; K D Muirden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

10.  Epitope specificity of antibodies to type II collagen in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  M J Rowley; I R Mackay; C A Brand; J F Bateman; D Chan
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.